Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 48 | 3,115 | 10,474 | 0 | 0 |
| Gross Profit | 48 | 3,115 | 10,474 | N/A | N/A |
| Operating Expenses | 7,380 | 5,377 | 8,292 | 8,335 | 15,039 |
| Operating Income | -7,332 | -2,262 | 2,182 | -8,335 | -15,039 |
| Interest Expense | 197 | 4 | 0 | 0 | 0 |
| Other Income | -43 | 11 | -553 | -107 | 443 |
| Pre-tax Income | -7,572 | -2,255 | 1,629 | -8,441 | -14,596 |
| Net Income Continuous | -7,572 | -2,255 | 1,629 | -8,441 | -14,596 |
| Net Income | $-7,572 | $-2,255 | $1,629 | $-8,441 | $-14,596 |
| EPS Basic Total Ops | -129.03 | -96.77 | 64.52 | -612.90 | -1,000.00 |
| EPS Basic Continuous Ops | -225.24 | -90.95 | 71.31 | -488.14 | -989.73 |
| EPS Diluted Total Ops | -129.03 | -96.77 | 64.52 | -612.90 | -1,000.00 |
| EPS Diluted Continuous Ops | -225.24 | -90.95 | 71.30 | -488.14 | -989.73 |
| EBITDA(a) | $-7,053 | $-2,155 | $2,576 | $-8,148 | $-14,874 |